A recent study identified circulating and tumor-infiltrating CD28+CD8+ Tregs with a CD25+, FOXP3+, CD152+, GITR+, CD194+, TGF-β+, and CD127− phenotype [107]. This evidence concerns the gene CD28 and neoplasm.